LOMOTIL DIN 00036323
Health Canada record
| Active ingredient(s) | DIPHENOXYLATE HYDROCHLORIDE 2.5 MG; ATROPINE SULFATE .025 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | A07DA01 DIPHENOXYLATE |
| Original market date | 31-Dec-1960 |
| Current status date | 23-Jan-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 463 | 2003-09-19 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 2202 | 2001-10-12 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for DIPHENOXYLATE HYDROCHLORIDE
0 valid EDQM Certificates of Suitability from 0 holders. 4 active FDA Drug Master Files.
Request a quote for LOMOTIL